Dennis Podlesak insider trades: Syndax Pharmaceuticals (SNDX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dennis reports to the SEC
and 1 more company
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | SNDX | ↓ Sell | 8,000 | $14.21 | $114K | Direct | Oct 30, 2026 (1d) |
| Aug 18, 2025 | SNDX | ↓ Sell | 57,600 | $15.19 | $875K | Direct | Aug 18, 2025 (0d) |
| Sep 16, 2022 | SNDX | ↓ Sell | 78,815 | $24.08 | $1.9M | Direct | Sep 16, 2022 (0d) |
| Apr 22, 2021 | SNDX | ↑ Buy | 13,967 | $14.11 | $197K | Direct | Apr 22, 2021 (0d) |
| May 31, 2006 | AVNR | ↑ Buy | 1,000 | $9.90 | $10K | Direct | Jun 2, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SNDX insiders
Open-market trades in the last 12 months
About Dennis Podlesak's insider trades
Dennis Podlesak is an insider at Syndax Pharmaceuticals (SNDX). Since May 31, 2006, Dennis has reported 2 open-market purchases worth $207K and 3 sales worth $2.9M on SEC Form 4. In the last 12 months: 1 sale ($114K).
Their filings also include grants and awards (30 filings), option exercises (3 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.